We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Genalyte and Barbara Davis Diabetes Center Collaborate

Product News   Aug 16, 2013

 
Genalyte and Barbara Davis Diabetes Center Collaborate
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

Owlstone Medical Announces Key Study Results on Use of Breath Biopsy for Improved Detection of Liver Disease Including NASH and NAFLD

Product News

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

READ MORE

PCR Biosystems Launches RiboShield™ RNase Inhibitor

Product News

PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE